Drug Trial Radar · NCT04634552
A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
Last checked: Nov 19, 2026Latest source record: Nov 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
510
Planned (sponsor's estimate)
Start
Feb 1, 2021
Primary completion
Jun 30, 2027
Study completion Mar 30, 2029
Sponsor
- Lead sponsor
- Janssen Research & Development, LLCJohnson & Johnson (Janssen) (JNJ)
- Sponsor type
- Industry
- First posted
- Nov 18, 2020
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the efficacy and safety of talquetamab in participants with relapsed or refractory multiple myeloma at the recommended Phase 2 dose(s) (RP2Ds) (Part 3).
Conditions
- Hematological Malignancies
Interventions
TalquetamabDrug
Talquetamab will be administered SC until disease progression.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Overall Response Rate (ORR)Time frame: Up to 2 years and 10 months
Locations
78 sites in 11 countries. Site status is shown where the registry gives one.
University of Alabama Birmingham
Birmingham, Alabama · Recruiting
University of Arkansas for Medical Sciences
Little Rock, Arkansas · Recruiting
City of Hope
Duarte, California · Completed
Memorial Healthcare System
Hollywood, Florida · Recruiting
Emory University Winship Cancer Institute
Atlanta, Georgia · Recruiting
University of Chicago
Chicago, Illinois · Completed
Norton Cancer Institute
Louisville, Kentucky · Recruiting
University of Michigan Health System
Ann Arbor, Michigan · Recruiting
Washington University School Of Medicine
St Louis, Missouri · Recruiting
NYU Langone Health
New York, New York · Active not recruiting
Mount Sinai Medical Center
New York, New York · Recruiting
University of Rochester Medical Center
Rochester, New York · Recruiting
Providence Portland Medical Center
Portland, Oregon · Completed
Tennessee Oncology
Nashville, Tennessee · Completed
UZ Antwerpen
Edegem, Belgium · Completed
UZ Leuven
Leuven, Belgium · Active not recruiting
CHU de Liège - Domaine Universitaire du Sart Tilman
Liège, Belgium · Active not recruiting
UCL - Saint Luc
Woluwe-Saint-Lambert, Belgium · Completed
Peking University Third Hospital
Beijing, China · Completed
Sun Yat Sen University Cancer Center
Guangzhou, China · Active not recruiting
The 1st Affiliated Hospital Of Medical College Zhejiang University 1
Hangzhou, China · Active not recruiting
The 1St Affiliated Hospital of Medical College Zhejiang University
Hangzhou, China · Active not recruiting
First Affiliated Hospital SooChow University
Suzhou, China · Active not recruiting
Institute of Hematology & Blood Disease Hospital Chinese Academy of Medical Science
Tianjin, China · Active not recruiting
The Second Affiliated Hospital of Xi'an Jiaotong University
Xi'an, China · Completed
The First Affiliated Hospital of Xian Jiaotong University
Xi'an, China · Completed
CHU Henri Mondor
Créteil, France · Active not recruiting
Hospices Civils de Lyon HCL
Lyon, France · Active not recruiting
CHU de Montpellier Hopital Saint Eloi
Montpellier, France · Active not recruiting
C.H.U. Hotel Dieu - France
Nantes, France · Active not recruiting
CHU de Bordeaux - Hospital Haut-Leveque
Pessac, France · Active not recruiting
Pôle IUC Oncopole CHU
Toulouse, France · Active not recruiting
Charite Campus Benjamin Franklin
Berlin, Germany · Active not recruiting
Universitaetsklinikum Heidelberg
Heidelberg, Germany · Active not recruiting
Universitaetsklinikum Muenster
Münster, Germany · Completed
Universitatsklinikum Wurzburg
Würzburg, Germany · Active not recruiting
Rambam Medical Center
Haifa, Israel · Active not recruiting
Carmel Medical Center
Haifa, Israel · Active not recruiting
Hadassah Medical Center
Jerusalem, Israel · Active not recruiting
Sheba Medical Center
Ramat Gan, Israel · Active not recruiting
Showing 40 of 78 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.